MONEY

Tyra Biosciences to Host Conference Call on Interim Clinical Data of TYRA-300 from SURF301 Phase 1/2 Study on October 25, 2024, at 8am ET

Tomas Kauer - ModeratorTomas Kauer - Moderator
Oct 24, 2024 - 08:00
Tyra Biosciences to Host Conference Call on Interim Clinical Data of TYRA-300 from SURF301 Phase 1/2 Study on October 25, 2024, at 8am ET
Read More

Tags:

Previous Article

Mother sues AI chatbot company Character.AI, Google over son's suicide

Next Article

GRUPO COMERCIAL CHEDRAUI, S.A.B. DE C.V. THIRD QUARTER 2024 RESULTS

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Tomas Kauer - Moderator
Tomas Kauer - Moderator

Related Posts

Aston Martin stock under pressure as 'benefits of refresh not visible until 2025' - HSBC

Aston Martin stock under pressure as 'benefits of refre...

Tomas Kauer - Mode... Oct 3, 2024

CLMB stock soars to all-time high, reaching $96.69

CLMB stock soars to all-time high, reaching $96.69

Tomas Kauer - Mode... Sep 18, 2024

Explosives put in devices before they arrived in Lebanon, says Lebanon's UN mission

Explosives put in devices before they arrived in Lebano...

Tomas Kauer - Mode... Sep 20, 2024